MedTrace Logo

Severe Asthma Research Program - Wake Forest University

NCT01750411 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2021-04-01

No results posted yet for this study

Summary

The mission of SARP is to improve the understanding of severe asthma through the integrated study of the effect of genetics on the clinical and biological features of asthma and to investigate how these change over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.

Conditions

  • Asthma
  • Severe Persistent Asthma

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Wake Forest University

    lead OTHER

Principal Investigators

  • Eugene R Bleecker, MD · University of Arizona Department of Medicine

  • Deborah A Meyers, PhD · University of Arizona Department of Medicine

  • Wendy C Moore, MD · Wake Forest University Health Sciences

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2020-02-18
Completion
2021-01-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01750411 on ClinicalTrials.gov